✦ LIBER ✦

Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy

✍ Scribed by Colombel, Jean Frederic; Loftus, Edward V.; Tremaine, William J.; Pemberton, John H.; Wolff, Bruce G.; Young-Fadok, Tonia; Harmsen, William S.; Schleck, Cathy D.; Sandborn, William J.

Book ID: 120400744
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 82 KB
Volume: 99
Category: Article
ISSN: 0002-9270
DOI: 10.1111/j.1572-0241.2004.04148.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab does not increase postoperati

Infliximab does not increase postoperative complication rates in patients with Crohn's disease

✍ Marchal, Ludwig; D'Haens, Geert; Assche, Gert Van; Hiele, Martin; D'Hoore, Andre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Periperative infliximab and/or immunomod

Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease

✍ Colombel, Jean F.; Loftus, Edward V.; Tremaine, William J.; Pemberton, John H.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Perioperative Treatment with Infliximab

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

✍ Hiroko Kunitake; Richard Hodin; Paul C. Shellito; Bruce E. Sands; Joshua Korzeni 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 161 KB

Perioperative Anti-Tumor Necrosis Factor

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

✍ Basil S. Nasir; Eric J. Dozois; Robert R. Cima; John H. Pemberton; Bruce G. Wolf 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 188 KB

1019 Perioperative Treatment with Inflix

1019 Perioperative Treatment with Infliximab (IFX) in Patients with Crohn's (CD) and Ulcerative Colitis (UC) Is Not Associated with Increased Rate of Postoperative Complications

✍ Kunitake, Hiroko; Hodin, Richard; Shellito, Paul C.; Sands, Bruce E.; Korzenik, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

DOP099 Five-year safety results from the

DOP099 Five-year safety results from the ENCORE registry: Malignancies in patients with Crohn's disease treated with infliximab, standard therapy, or switched from standard therapy to infliximab

✍ D'Haens, G.; Reinisch, W.; Colombel, J.-F.; Panes, J.; Ghosh, S.; Prantera, C.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 47 KB